Brazilian Health Regulatory Agency approves trial of Oxford COVID-19 Vaccine
On 2 June, the Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials conducted by Oxford University and supported by AstraZeneca, considering 2,000 volunteers to be tested in the country. On April 30, the University of Oxford and AstraZeneca announced an agreement for the global development and distribution of the […]